Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine [NA]

View source ↗

Summary

This terminated clinical trial evaluated the effectiveness of an electronic health record interface in reducing hydroxychloroquine dosing for patients with rheu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Rheumatic Diseases | NA | Status: TERMINATED